Ident. | Authors (with country if any) | Title |
---|
000C25 |
Louise Barbier [Australie, France] ; SZUN SZUN TAY [Australie] ; Claire Mcguffog [Australie] ; James A. Triccas [Australie] ; Geoffrey W. Mccaughan [Australie] ; David G. Bowen [Australie] ; Patrick Bertolino [Australie] | Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation |
001363 |
Rhys S. Allan [France] ; Elina Zueva [France] ; Florence Cammas [France] ; Heidi A. Schreiber [France, Australie, États-Unis] ; Vanessa Masson [France, Australie] ; Gabrielle T. Belz [Australie] ; Daniele Roche [France] ; Christele Maison [France] ; Jean-Pierre Quivy [France] ; Genevieve Almouzni [France] ; Sebastian Amigorena [France] | An epigenetic silencing pathway controlling T helper 2 cell lineage commitment |
001544 |
Revital Aricha [Israël] ; Tali Feferman [Israël] ; Hamish S. Scott [Australie] ; Miriam C. Souroujon [Israël] ; Sonia Berrih-Aknin [France] ; Sara Fuchs [Israël] | The susceptibility of Aire-/- mice to experimental myasthenia gravis involves alterations in regulatory T cells |
001667 |
Edwige Roy [France] ; Michele Leduc [France] ; Sarah Guegan [France] ; Latif Rachdi [France] ; Nicolas Kluger [France] ; Raphael Scharfmann [France] ; Selim Aractingi [France] ; Kiarash Khosrotehrani [France, Australie] | Specific maternal microchimeric T cells targeting fetal antigens in β cells predispose to auto-immune diabetes in the child |
001953 |
R. Mallone [France] ; S. I. Mannering [Australie] ; B. M. Brooks-Worrell [États-Unis] ; I. Durinovic-Bello [États-Unis] ; C. M. Cilio [Suède] ; F. S. Wong [Royaume-Uni] ; N. C. Schloot [Allemagne] | Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society |
001C36 |
Alison M. Mcdonnell [Australie] ; Anna K. Nowak [Australie] ; Richard A. Lake [Australie] | Contribution of the immune system to the chemotherapeutic response |
001C76 |
MICHELLE HONG [Singapour] ; Anne-Laure Puaux [Singapour] ; Caleb Huang [Singapour] ; Laure Loumagne [Singapour] ; Charlene Tow [Singapour] ; Charles Mackay [Australie] ; Masashi Kato [Japon] ; Armelle Prevost-Blondel [France] ; Marie-Françoise Avril [France] ; Alessandra Nardin [Singapour] ; Jean-Pierre Abastado [Singapour] | Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control |
002004 |
Biju Krishnan [Royaume-Uni] ; Monica Else [Royaume-Uni] ; Geir E. Tjonnfjord [Norvège] ; Bruno Cazin [France] ; Dennis Carney [Australie] ; John Carter [Nouvelle-Zélande] ; Nicolas Ketterer [Suisse] ; Daniel Catovsky [Royaume-Uni] ; Mark Ethell [Royaume-Uni] ; Estella Matutes [Royaume-Uni] ; Claire E. Dearden [Royaume-Uni] | Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study |
002528 |
S. I. Mannering [Australie] ; F. S. Wong [Royaume-Uni] ; I. Durinovic-Bello [États-Unis] ; B. Brooks-Worrell [États-Unis] ; T. I. Tree [Royaume-Uni] ; C. M. Cilio [Suède] ; N. C. Schloot [Allemagne] ; R. Mallone [France] | Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes |
002618 |
Ann M. Arvin [États-Unis] ; Stefan Oliver [États-Unis] ; Mike Reichelt [États-Unis] ; Jennifer F. Moffat [États-Unis] ; Marvin Sommer [États-Unis] ; Leigh Zerboni [États-Unis] ; Barbara Berarducci [France] | Analysis of the Functions of Glycoproteins E and I and Their Promoters During VZV Replication In Vitro and in Skin and T-Cell Xenografts in the SCID Mouse Model of VZV Pathogenesis |
004175 |
Jintanat Ananworanich [Thaïlande] ; Angèle Gayet-Ageron [Suisse] ; Michelle Le Braz [Suisse] ; Wisit Prasithsirikul [Thaïlande] ; Ploenchan Chetchotisakd [Thaïlande] ; Sasisopin Kiertiburanakul [Thaïlande] ; Warangkana Munsakul [Thaïlande] ; Phitsanu Raksakulkarn [Thaïlande] ; Somboon Tansuphasawasdikul [Thaïlande] ; Sunee Sirivkhayakul [Thaïlande] ; Matthias Cavassini [Suisse] ; Urs Karrer [Suisse] ; Daniel Genne [Suisse] ; Reto Nuesch [Suisse] ; Pietro Vernazza [Suisse] ; Enos Bernasconi [Suisse] ; Dominic Leduc [France] ; Claudette Satchell [Australie] ; Sabine Yerly [Suisse] ; Luc Perrin [Suisse] ; Andrew Hill [Royaume-Uni] ; Thomas Perneger [Suisse] ; Praphan Phanuphak [Thaïlande] ; Hansjakob Furrer [Suisse] ; David Cooper [Thaïlande, Australie] ; Kiat Ruxrungtham [Thaïlande] ; Bernard Hirschel [Suisse] | CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1 : results of the staccato randomised trial |
004334 |
Kirilee A. Wilson [Australie] ; Séverine B R [France] ; Anne L. Maerz [Australie] ; Marc Alizon [France] ; Pantelis Poumbourios [Australie] | The conserved glycine-rich segment linking the N-terminal fusion peptide to the coiled coil of human T-cell leukemia virus type 1 transmembrane glycoprotein gp21 is a determinant of membrane fusion function |
004436 |
Tamara N. Shenkier [Canada, France, États-Unis, Pays-Bas, Allemagne, Italie, Australie] ; Jean-Yves Blay ; Brian Patrick O'Neill ; Philip Poortmans ; Eckhard Thiel ; Kristoph Jahnke ; Lauren E. Abrey ; Edward Neuwelt ; Richard Tsang ; Tracy Batchelor ; Nancy Harris ; Andrés J. M. Ferreri ; Maurilio Ponzoni ; Peter O'Brien ; James Rubenstein ; Joseph M. Connors | Primary CNS lymphoma of T-cell origin: A descriptive analysis from the International Primary CNS Lymphoma Collaborative Group |
004A40 |
Eugene Maraskovsky [Australie] ; Sigrid Sjölander [Australie] ; Debbie P. Drane [Australie] ; Max Schnurr [Australie] ; Thuy T. T. Le [Australie] ; Luis Mateo [Australie] ; Thomas Luft [Australie] ; Kelly-Anne Masterman [Australie] ; Tsin-Yee Tai [Australie] ; QIYUAN CHEN [Australie] ; Simon Green [Australie] ; Anders Sjölander [Australie] ; Martin J. Pearse [Australie] ; Francois A. Lemonnier [France] ; WEISAN CHEN [Australie] ; Jonathan Cebon [Australie] ; Andreas Suhrbier [Australie] | NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ T-cell-mediated immunity and protection against NY-ESO-1+ tumors |
004C36 |
Bonaventura Clotet [Espagne] ; Francois Raffi [France] ; David Cooper [Australie] ; Jean-Frangois Delfraissy [France] ; Adriano Lazzarin [Italie] ; Graeme Moyle [Royaume-Uni] ; Jürgen Rockstroh [Allemagne] ; Vincent Soriano [Espagne] ; Jonathan Schapiro [Israël] | Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations |
004E13 |
Sarah A. Robertson [Australie] ; John J. Bromfield [Australie] ; Kelton P. Tremellen [Australie] | Seminal 'priming' for protection from preeclampsia: a unifying hypothesis |
004E53 |
John J. Zaunders [Australie, États-Unis, France] ; Laure Moutouh-De Parseval ; Shinichi Kitada ; John C. Reed ; Steffney Rought ; Davide Genini ; Lorenzo Leoni ; Anthony Kelleher [Australie] ; David A. Cooper [Australie] ; Don E. Smith [Australie] ; Pat Grey [Australie] ; Jérome Estaquier [Australie] ; Susan Little ; Douglas D. Richman ; Jacques Corbeil | Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: Regulation by interleukin (IL)-2, IL-15, and Bcl-2 |
004E95 |
Hamida Hammad [France] ; Hermelijn H. Smits [Pays-Bas] ; Céline Ratajczak [France] ; Asokananthan Nithiananthan [Australie] ; Eddy A. Wierenga [Pays-Bas] ; Geoffrey A. Stewart [Australie] ; Alain Jacquet [Belgique] ; Andrd-Bernard Tonnel [France] ; Joël Pestel [France] | Monocyte-derived dendritic cells exposed to Der p 1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22 |
004F18 |
S. Hacein-Bey-Abina [France] ; C. Von Kalle [France, Allemagne, États-Unis] ; M. Schmidt [Allemagne] ; M. P. Mccormack [Royaume-Uni] ; N. Wulffraat [Pays-Bas] ; P. Leboulch [États-Unis] ; A. Lim [France] ; C. S. Osborne [Guinée] ; R. Pawliuk [États-Unis] ; E. Morillon [France] ; R. Sorensen [France] ; A. Forster [Royaume-Uni] ; P. Fraser [Guinée] ; J. I. Cohen [États-Unis] ; G. De Saint Basile [France] ; I. Alexander [Australie] ; U. Wintergerst [Allemagne] ; T. Frebourg [France] ; A. Aurias [France] ; D. Stoppa-Lyonnet [France] ; S. Romana [France] ; I. Radford-Weiss [France] ; F. Gross [France] ; F. Valensi [France] ; E. Delabesse [France] ; E. Macintyre [France] ; F. Sigaux [France] ; J. Soulier [France] ; L. E. Leiva [États-Unis] ; M. Wissler [Allemagne] ; C. Prinz [Allemagne] ; T. H. Rabbitts [Royaume-Uni] ; F. Le Deist [France] ; A. Fischer [France] ; M. Cavazzana-Calvo [France] | LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 |
005092 |
Stuart I. Mannering [Australie] ; Jessica S. Morris [Australie] ; Kent P. Jensen [Australie] ; Anthony W. Purcell [Australie] ; Margo C. Honeyman [Australie] ; Peter M. Van Endert [France] ; Leonard C. Harrison [Australie] | A sensitive method for detecting proliferation of rare autoantigen-specific human T cells |
005200 |
Philippe Vanhems [France] ; Emmanuelle Caillat-Vallet [France] ; Bernard Hirschel [Suisse] ; Jean-Pierre Routy [Canada] ; Andrew Carr [Australie] ; Jeanette Vizzard [Australie] ; David A. Cooper [Australie] ; Luc Perrin [Suisse] | The CD4 cell count 3 months after acute retroviral syndrome is associated with the presence of AIDS in the source individual |
005296 |
Stuart J. Rodda [Australie] | Peptide libraries for T cell epitope screening and characterization |
005302 |
Richard Tilling [Royaume-Uni] ; Sabine Kinloch [Royaume-Uni] ; Li-Ean Goh [Royaume-Uni] ; David Cooper [Australie] ; Luc Perrin [Suisse] ; Fiona Lampe [Royaume-Uni] ; John Zaunders [Australie] ; Bruno Hoen [France] ; Chris Tsoukas [Canada] ; Jan Andersson [Suède] ; George Janossya [Royaume-Uni] | Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection |
005318 |
Marlene L. Rose [Royaume-Uni] ; John Smith [Royaume-Uni] ; Georges Dureau [France] ; Anne Keogh [Australie] ; Jon Kobashigowa [États-Unis] | Mycophenolate mofetil decreases antibody production after cardiac transplantation |
005666 |
Hamida Hammad [France, Belgique, Australie] ; Anne-Sophie Charbonnier ; Catherine Duez ; Alain Jacquet ; Geoffrey A. Stewart ; André-Bernard Tonnel ; Joël Pestel | Th2 polarization by Der p 1-pulsed monocyte-derived dendritic cells is due to the allergic status of the donors |
005684 |
Caroline Demangel [Australie, France] ; Umaimainthan Palendira [Australie] ; Carl G. Feng [Australie] ; Andrew W. Heath [Royaume-Uni] ; Andrew G. D. Bean [Australie] ; Warwick J. Britton [Australie] | Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection |
005718 |
Daniel L. Kaufman [États-Unis] ; Roland Tisch [États-Unis] ; Nora Sarvetnick [États-Unis] ; Lucienne Chatenoud [France] ; Leonard C. Harrison [Australie] ; Kathryn Haskins [États-Unis] ; Anthony Quinn [États-Unis] ; Eli Sercarz [États-Unis] ; Bhagi Singh [Canada] ; Matthias Von Herrath [États-Unis] ; Dale Wegmann [États-Unis] ; LI WEN [États-Unis] ; Dan Zekzer [États-Unis] | Report from the 1st International NOD mouse T-cell workshop and the follow-up mini-workshop |
005740 |
Carl G. Feng [Australie] ; Umaimainthan Palendira [Australie] ; Caroline Demangel [Australie, États-Unis] ; Joanne M. Spratt [Australie] ; Adam S. Malin [France] ; Warwick J. Britton [Australie, Royaume-Uni] | Priming by DNA immunization augments protective efficacy of Mycobacterium bovis bacille Calmette-Guerin against tuberculosis |
005828 |
John J. Zaunders [France] ; Gilbert R. Kaufmann [Australie] ; Philip H. Cunningham [France] ; Don Smith [Australie] ; Pat Grey [Australie] ; Kazuo Suzuki [France] ; Andrew Carr [France] ; Li-Ean Goh [Royaume-Uni] ; David A. Cooper [France] | Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection |
005932 |
Vanderson Rocha [France, Royaume-Uni, États-Unis, Italie, Autriche, Suède, Australie, Japon, Espagne, Allemagne] ; Jacqueline Cornish ; Eric L. Sievers ; Alexandra Filipovich ; Franco Locatelli ; Cristina Peters ; Mats Remberger ; Gérard Michel ; William Arcese ; Sandro Dallorso ; Karin Tiedemann ; Alessandro Busca ; Ka-Wah Chan ; Shunichi Kato ; Juan Ortega ; Marcus Vowels ; Axel Zander ; Gérard Souillet ; Anthony Oakill ; Ann Woolfrey ; Andrea L. Pay ; Ann Green ; Federico Garnier ; Irina Lonescu ; Peter Wernet ; Girolamo Sirchia ; Pablo Rubinstein ; Sylvie Chevret ; Eliane Gluckman | Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia |
005A72 |
C. J. Lees [Australie] ; V. Apostolopoulos [Australie] ; B. Acres [France] ; C.-S. Ong [Australie] ; V. Popovski [Australie] ; I. F. C. Mckenzie [Australie] | The effect of T1 and T2 cytokines on the cytotoxic T cell response to mannan-MUC1 |
005C25 |
B. Acres [France] ; V. Apostolopoulos [Australie] ; J.-M. Balloul [France] ; D. Wreschner [Israël] ; P.-X. Xing [Australie] ; D. Ali-Hadji [France] ; N. Bizouarne [France] ; M. P. Kieny [France] ; I. F. C. Mckenzie [Australie] | MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines |
005C53 |
Catherine J. Lees [Australie] ; Vasso Apostolopoulos [Australie] ; Bruce Acres [France] ; Ian Ramshaw [Australie] ; Alistair Ramsay [Australie] ; Chin-Swee Ong [Australie] ; Ian F. C. Mckenzie [Australie] | Immunotherapy with mannan-MUC1 and IL-12 in MUC1 transgenic mice |
005D43 |
P. Vanhems [France, États-Unis] ; J. Hughes [États-Unis] ; A. C. Collier [États-Unis] ; J. Vizzard [Australie] ; L. Perrin [Suisse] ; D. A. Cooper [Australie] ; B. Hirschel [Suisse] ; L. Corey [États-Unis] | Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and Sydney |
005F12 |
W. R. Kem [États-Unis] ; M. W. Pennington [États-Unis] ; R. S. Norton [Australie] | Sea anemone toxins as templates for the design of immunosuppressant drugs |
006077 |
E. Comoy [France] ; J. Pestel [France] ; G. A. Stewart [Australie] ; F. Finkelman [États-Unis] ; A. Capron [France] ; G. Thyphronitis [France] | Do allergens induce type-2 immune responses? |
006336 |
R. Khanna [Australie] ; P. Busson [France] ; S. R. Burrows [Australie] ; C. Raffoux [France] ; D. J. Moss [Australie] ; J. M. Nicholls [Hong Kong] ; L. Cooper [Australie] | Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): Evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells |
006400 |
J. R. Passweg [États-Unis] ; P. Tiberghien [France] ; J.-Y. Cahn [France] ; M. R. Vowels [Australie] ; B. M. Camitta [États-Unis] ; R. P. Gale [États-Unis] ; R. H. Herzig [États-Unis] ; D. Hoelzer [Allemagne] ; M. M. Horowitz [États-Unis] ; N. Ifrah [France] ; J. P. Klein [États-Unis] ; D. I. Marks [États-Unis] ; N. K. C. Ramsay [États-Unis] ; P. A. Rowlings [États-Unis] ; D. J. Weisdorf [États-Unis] ; M.-J. Zhang [États-Unis] ; A. J. Barrett [États-Unis] | Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia |
006885 |
N. Signoret [France] ; D. Blanc-Zouaoui [Australie] ; P. D. Kwong [États-Unis] ; Q. J. Sattentau [France] | Selective effects of electrostatic changes in the CD4 CDR-3-like loop on infection by different human immunodeficiency virus type 1 isolates |
006B45 |
G. E. Grau [Suisse] ; C. Behr [France] | T cells and malaria: is Th1 cell activation a prerequisite for pathology? |